- Home
- TLX vs SLG Comparison
TLX vs SLG Comparison
Compare TLX & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- SLG
- Stock Information
- Founded
- TLX 2015
- SLG 1980
- Country
- TLX Australia
- SLG United States
- Employees
- TLX N/A
- SLG N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- SLG Real Estate Investment Trusts
- Sector
- TLX Health Care
- SLG Real Estate
- Exchange
- TLX Nasdaq
- SLG Nasdaq
- Market Cap
- TLX 5.7B
- SLG 4.6B
- IPO Year
- TLX N/A
- SLG 1997
- Fundamental
- Price
- TLX $15.57
- SLG $63.42
- Analyst Decision
- TLX Strong Buy
- SLG Hold
- Analyst Count
- TLX 3
- SLG 16
- Target Price
- TLX $22.33
- SLG $65.56
- AVG Volume (30 Days)
- TLX 50.1K
- SLG 1.1M
- Earning Date
- TLX 01-01-0001
- SLG 07-16-2025
- Dividend Yield
- TLX N/A
- SLG 4.81%
- EPS Growth
- TLX 798.14
- SLG N/A
- EPS
- TLX 0.09
- SLG N/A
- Revenue
- TLX $484,687,790.00
- SLG $648,551,000.00
- Revenue This Year
- TLX N/A
- SLG N/A
- Revenue Next Year
- TLX N/A
- SLG $1.50
- P/E Ratio
- TLX $168.47
- SLG N/A
- Revenue Growth
- TLX 55.85
- SLG N/A
- 52 Week Low
- TLX $13.61
- SLG $45.15
- 52 Week High
- TLX $30.36
- SLG $82.81
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- SLG 58.35
- Support Level
- TLX N/A
- SLG $60.48
- Resistance Level
- TLX N/A
- SLG $64.07
- Average True Range (ATR)
- TLX 0.00
- SLG 1.90
- MACD
- TLX 0.00
- SLG -0.10
- Stochastic Oscillator
- TLX 0.00
- SLG 83.24
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.